Tout­ing nine-fig­ure deal pack­age, Pfiz­er ex­tends col­lab­o­ra­tion with AI part­ner

More than two years af­ter Pfiz­er tied the knot with ma­chine learn­ing firm Cy­toRe­a­son in an AI-fo­cused deal, the two com­pa­nies have agreed to keep the part­ner­ship alive for at least five more years.

Cy­toRe­a­son, a Big Phar­ma part­ner in its own right with Sanofi, Mer­ck and Roche as clients, an­nounced the ex­ten­sion on Tues­day, elab­o­rat­ing more on the com­pa­ny’s part­ner­ship with the Big Phar­ma gi­ant that has been on­go­ing since be­fore Pfiz­er’s his­toric Covid-19 vac­cine Comir­naty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER